Uterine Leiomyosarcoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2015-11-18
Clinical Trial Update: Pazopanib for Treating Uterine Leiomyosarcoma [Phase 2]
The Phase 2 clinical trial of pazopanib for treating uterine leiomyosarcoma has been withdrawn.